This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Wed, 08/02/2023 - 19:58 August 2, 2023 — An accepted manuscript published in the American Journal of Roentgenology (AJR) found that deploying a radiomic-based model with T2-weighted MRI data could increase diagnostic accuracy for pediatric Crohn disease (CD). Dillman , MD, MSc. Dillman et al.’s and accuracy of 89.6%.
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Food and Drug Administration, with a decision expected by the end of 2023. Donanemab is currently under review for approval by the U.S.
christine.book Mon, 06/26/2023 - 12:46 June 26, 2023 — PET imaging with 68Ga-FAPI offers a feasible, reliable, and reproducible method for evaluating disease activity in rheumatoid arthritis, according to new research presented at the 2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
Based on a novel clustering framework using sparse canonical correlation analysis (SCCA), the integrated approach was successful in identifying four subtypes of Alzheimer’s disease and the top genes associated with each, according to the authors of the study, “An SCCA-clustering framework for Alzheimer’s disease subtyping using tau PET and genomics.”
Welcome to the first installment of this year’s Road to RSNA preview of the RSNA 2023 meeting. AI’s capability and potential to enhance the practice of radiology will take center stage at RSNA 2023. For more information on those presentations and other abstracts, check out the RSNA 2023 meeting program. 9:40 a.m. | 9:40 a.m. |
Food and Drug Administration has approved this technology for the treatment of essential tremor and Parkinson's disease, and its indications are expanding to include various intracranial diseases. High-intensity FUS is a safe and effective treatment for various intracranial diseases.
Is there a signature biomarker for younger/early-onset Alzheimer’s Disease (EOAD)? Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied. What Are the Clinical Implications? We were able to prove that the EOAD signature is a clinically valid measure of AD-related neurodegeneration.
And 2023 is no exception. The technology figured prominently in five Minnies categories, including Hottest Clinical Procedure. Workforce shortages were deemed by our Expert Panel to be the biggest threat in 2023. Each year, the Minnies award winners reflect the current challenges, issues, and advances in radiology.
milla1cf Tue, 09/26/2023 - 15:32 September 26, 2023 — In a study of more than 2,000 chest X-rays , radiologists outperformed AI in accurately identifying the presence and absence of three common lung diseases, according to a study published in Radiology , a journal of the Radiological Society of North America ( RSNA ).
Exciting presentations will cover a generative AI model that shows potential for making surgical planning for total hip arthroplasty (THA) more efficient and a deep-learning model developed to identify individuals at high risk of chronic obstructive pulmonary disease (COPD). 1:10 p.m. | 2:00 p.m. | 3:20 p.m. | 8:40 a.m. | 9:20 a.m. |
tesla) is as clinically useful as conventional 1-tesla and 3-tesla systems for applications ranging from point-of-care MRI for critically ill patients to lumbar spine visualization. For more information on the presentations we're highlighting below and other abstracts, take a look at the RSNA 2023 meeting program. 11:10 a.m. |
LifeQ offers a 24/7 lens into the body, generating actionable health insights from personal wearable devices and assisting in screening for disease and illness and uncovering its root cause," stated Laurie Olivier, LifeQ CEO and co-founder.
Photon-counting CT may serve as an alternative to MRI for assessing liver fat in patients with fatty liver disease, according to an article published September 24 in Radiology. The disease affects up to 24% of the population in the U.S. and can lead to cirrhosis and even cancer if left untreated. in the MASLD cohort.
milla1cf Mon, 09/25/2023 - 15:57 September 25, 2023 — Viz.ai , a leader in AI -powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in pulmonary embolism (PE) detection. For more information: https ://www.viz.ai/vascular
christine.book Tue, 10/03/2023 - 11:37 October 3, 2023 — Medical device company GT Medical Technologies, Inc. 2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA.
The Boston, MA-based company has announced multiple sessions to demonstrate its industry-leading Clinical Natural Language Understanding (cNLU) technology at HIMSS 2023. Doctor vs. AI: Clinical Natural Language Processing for Preoperative Care — Join Kevin Agatstein and Dr. CT) at the McCormick Center, South Building S104.
milla1cf Wed, 11/08/2023 - 13:06 November 8, 2023 — Agamon Health is a healthcare technology company that uses Generative AI and workflow automation to close gaps in patient care. In collaboration with Mayo Clinic through a know-how agreement, Agamon Health aims to extend its offering to cardiology.
christine.book Thu, 06/29/2023 - 12:17 June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, SNMMI 2023 , found that personalized dosing of men with prostate cancer resulted in improved patient outcomes. Thursday, June 29, 2023 - 12:17
The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor. The guideline is published in Practical Radiation Oncology.
milla1cf Tue, 10/03/2023 - 12:04 October 3, 2023 — The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. This study provides a possible link between metastasis-direction radiation, the systemic immune response and overall disease control.
christine.book Mon, 06/26/2023 - 11:55 June 26, 2023 — A first-in-human evaluation of the novel theranostic pair 68Ga-DOTA-5G / 177Lu-DOTA-ABM-5G has confirmed its ability to successfully detect metastatic pancreatic cancer and visualize targeted treatment of the disease. Wagner, Jr., Image of the Year.
milla1cf Thu, 08/03/2023 - 20:56 August 3, 2023 — The Mount Sinai Medical Legal Partnership ( MSMLP ), which provides legal aid to Mount Sinai Health System patients in need, has launched a clinic to help breast cancer patients navigate legal issues that arise due to their diagnoses.
milla1cf Mon, 06/12/2023 - 21:11 June 12, 2023 — Results of clinical trials are only as good as the data upon which they rest. At UIC, the authors are part of an NIH-funded study on using guided relaxation and acupuncture to reduce the chronic pain of sickle cell disease.
mtaschetta-millane Fri, 07/19/2024 - 09:25 July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s clinical artificial intelligence (AI) software business for total consideration of approximately $51 million.
milla1cf Mon, 04/24/2023 - 14:14 April 24, 2023 — Diagnostic imaging is indispensable in healthcare, as it allows clinicians to detect and diagnose a variety of medical conditions. This technique is significantly cheaper than clinical medical imaging techniques, while providing similar functions.”
Schuchter, MD, FASCO , the Madlyn and Leonard Abramson Professor of Clinical Oncology and director of the Tara Miller Melanoma Center at Penn Medicine , is the 2023-2024 ASCO President, and the ASCO Annual Meeting program features more than 200 sessions complementing her Presidential Theme: "The Art and Science of Cancer Care: From Comfort to Cure."
milla1cf Mon, 06/12/2023 - 21:13 June 12, 2023 — Cancer that spreads to the brain from another part of the body such as lung or breast is called a metastatic brain tumor. The two-year meningeal disease rate was 5.8%, and the two-year symptomatic adverse radiation effect rate was 5%.
milla1cf Wed, 12/06/2023 - 18:20 December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., Under the agreement, the Philogen Group is conducting a Phase 1 clinical study to evaluate the safety and dosimetry of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) in patients with solid tumors.
christine.book Tue, 06/20/2023 - 14:03 June 20, 2023 — Ascelia Pharma presented data from its Orviglance Hepatic Impairment study during the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) 2023 annual meeting held June 14-16 in Valencia, Spain.
milla1cf Fri, 11/03/2023 - 12:22 November 3, 2023 — Guerbet , a global leader in medical imaging with more than 30 years of experience in MRI, announced today its schedule of activities at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting from November 26-30 in Chicago, IL.
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. Interventional In image-guided surgery activities, GEHC showcased two new AI applications previously presented at ECR 2023. MRI GEHC unveiled Signa Champion, a 1.5-tesla,
Currently, when treating metastatic breast cancer patients, oncologists base clinical decisions on diagnostic tools including biopsy results which only represent the sampled area of the tumor. For more information: www.gehealthcare.com References: 1 J Nucl Med 2023 Mar;64(3):351-354. In the U.S., doi: 10.2967/jnumed.123.265420
milla1cf Thu, 11/23/2023 - 06:00 November 23, 2023 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, is unveiling several new medical systems at the 2023 Radiological Society of North America ( RSNA ) annual meeting, booth #1929, held November 26 – 30 at McCormick Place in Chicago.
began clinical trials in late 2023. received additional seed funding in early September 2023 to support clinical trials and engineering projects. UC San Diego Health is the first site for the clinical trials to be conducted. UC San Diego Health is the first site for the clinical trials to be conducted.
milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1
milla1cf Tue, 05/23/2023 - 11:36 May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages , according to a new national survey from the American Society for Radiation Oncology ( ASTRO ). Radiation oncologists from across the country are in Washington, D.C.
milla1cf Tue, 10/17/2023 - 12:49 October 17, 2023 — Halo Precision Diagnostics , a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer , a global leader in radiology, to join QUANTI, Bayer’s Phase III clinical development program for gadoquatrane.
Food and Drug Administration (FDA) on May 25, 2023. We believe it further validates the clinical utility of POSLUMA in patients with newly diagnosed or recurrent prostate cancer, and can help expand patient access. POSLUMA was approved by the U.S. Chief Executive Officer of the Company. “We Teoh, MBBS, MRCP, FRCR, D.Phil.,
Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.
Alzheimer disease is a progressive, irreversible brain disorder that slowly degrades memory and cognitive function. While previous treatment methods focused on addressing Alzheimer disease symptoms, recent approvals of monoclonal antibodies have provided a path to target the underlying disease itself. In June 2021, the U.S.
milla1cf Tue, 10/17/2023 - 13:07 October 17, 2023 — Radionetics Oncology, Inc., Adrenocortical carcinoma is a disease with a desperate need for new agents, as the last drug approved by the FDA was in 1970. Despite significant research efforts, the median survival of patients with metastatic disease is less than 15 months.
milla1cf Tue, 04/11/2023 - 21:21 April 11, 2023 — The American College of Radiology ( ACR ) released an update to its ACR Appropriateness Criteria (ACR AC), which includes 227 diagnostic imaging and interventional radiology topics with more than 1,080 clinical variants covering 3,000 clinical scenarios.
milla1cf Thu, 10/12/2023 - 12:06 October 12, 2023 — The American College of Radiology ( ACR ) released an update to its ACR Appropriateness Criteria (ACR AC), which includes 233 diagnostic imaging and interventional radiology topics with more than 1,100 clinical variants covering more than 3,000 clinical scenarios.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content